Kennedy Capital Management, Inc. Abeona Therapeutics Inc. Transaction History
Kennedy Capital Management, Inc.
- $3.99 Billion
- Q1 2025
A detailed history of Kennedy Capital Management, Inc. transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Kennedy Capital Management, Inc. holds 621,763 shares of ABEO stock, worth $4.25 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
621,763Holding current value
$4.25 Million% of portfolio
0.07%Shares
1 transactions
Others Institutions Holding ABEO
# of Institutions
79Shares Held
27.8MCall Options Held
556KPut Options Held
34.9K-
Suvretta Capital Management, LLC New York, NY3.69MShares$25.2 Million0.77% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.51MShares$24 Million0.75% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.69MShares$18.4 Million0.02% of portfolio
-
Western Standard LLC Los Angeles, CA2.28MShares$15.6 Million6.48% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.02MShares$13.8 Million0.0% of portfolio
About ABEONA THERAPEUTICS INC.
- Ticker ABEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,950,380
- Market Cap $40.7M
- Description
- Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...